These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25122464)

  • 21. The effect of moderate-dose versus double-dose statins on patients with acute coronary syndrome in China: Results of the CHILLAS trial.
    Zhao SP; Yu BL; Peng DQ; Huo Y
    Atherosclerosis; 2014 Apr; 233(2):707-712. PubMed ID: 24603217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of statin therapy on incident type 2 diabetes mellitus in patients with clinically manifest vascular disease.
    van de Woestijne AP; van der Graaf Y; Westerink J; Nathoe HM; Visseren FL
    Am J Cardiol; 2015 Feb; 115(4):441-6. PubMed ID: 25554536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of combination therapy with statin and another lipid-modifying agent compared with intensified statin monotherapy: a systematic review.
    Gudzune KA; Monroe AK; Sharma R; Ranasinghe PD; Chelladurai Y; Robinson KA
    Ann Intern Med; 2014 Apr; 160(7):468-76. PubMed ID: 24514899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statins, low-density lipoprotein cholesterol, and risk of cancer.
    Alsheikh-Ali AA; Trikalinos TA; Kent DM; Karas RH
    J Am Coll Cardiol; 2008 Sep; 52(14):1141-7. PubMed ID: 18804740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events.
    Zhan S; Tang M; Liu F; Xia P; Shu M; Wu X
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012502. PubMed ID: 30480766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis.
    Law MR; Wald NJ; Rudnicka AR
    BMJ; 2003 Jun; 326(7404):1423. PubMed ID: 12829554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of HMG CoA reductase inhibitors on low-density lipoprotein cholesterol and C-reactive protein: systematic review and meta-analysis.
    Genser B; Grammer TB; Stojakovic T; Siekmeier R; März W
    Int J Clin Pharmacol Ther; 2008 Oct; 46(10):497-510. PubMed ID: 18826864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensive statin therapy for Indians: Part-I. Benefits.
    Enas EA; Pazhoor HC; Kuruvila A; Vijayaraghavan K
    Indian Heart J; 2011; 63(3):211-27. PubMed ID: 22734339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-achievement of LDL-cholesterol targets in patients with diabetes at very-high cardiovascular risk receiving statin treatment: Incidence and risk factors.
    Breuker C; Clement F; Mura T; Macioce V; Castet-Nicolas A; Audurier Y; Boegner C; Morcrette E; Jalabert A; Villiet M; Avignon A; Sultan A
    Int J Cardiol; 2018 Oct; 268():195-199. PubMed ID: 30041785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Achievement of recommended lipid and lipoprotein levels with combined ezetimibe/statin therapy versus statin alone in patients with and without diabetes.
    Guyton JR; Betteridge DJ; Farnier M; Leiter LA; Lin J; Shah A; Johnson-Levonas AO; Brudi P
    Diab Vasc Dis Res; 2011 Apr; 8(2):160-72. PubMed ID: 21562068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis.
    Silverman MG; Ference BA; Im K; Wiviott SD; Giugliano RP; Grundy SM; Braunwald E; Sabatine MS
    JAMA; 2016 Sep; 316(12):1289-97. PubMed ID: 27673306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety for the achievement of guideline-recommended lower low-density lipoprotein cholesterol levels: a systematic review and meta-analysis.
    Khan SU; Khan MU; Virani SS; Khan MS; Khan MZ; Rashid M; Kalra A; Alkhouli M; Blaha MJ; Blumenthal RS; Michos ED
    Eur J Prev Cardiol; 2022 Feb; 28(18):2001-2009. PubMed ID: 33624058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ezetimibe in high-risk, previously treated statin patients: a systematic review and network meta-analysis of lipid efficacy.
    Lorenzi M; Ambegaonkar B; Baxter CA; Jansen J; Zoratti MJ; Davies G
    Clin Res Cardiol; 2019 May; 108(5):487-509. PubMed ID: 30302558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy.
    Monson JP; Jönsson P; Koltowska-Häggström M; Kourides I
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):623-8. PubMed ID: 17581260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of different statin therapy to change low-density lipoprotein cholesterol and high-density lipoprotein cholesterol level in Korean patients with and without diabetes.
    Khang AR; Song YS; Kim KM; Moon JH; Lim S; Park KS; Jang HC; Choi SH
    J Clin Lipidol; 2016; 10(3):528-537.e3. PubMed ID: 27206940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statin therapy on glycaemic control in type 2 diabetes: a meta-analysis.
    Zhou Y; Yuan Y; Cai RR; Huang Y; Xia WQ; Yang Y; Wang P; Wei Q; Wang SH
    Expert Opin Pharmacother; 2013 Aug; 14(12):1575-84. PubMed ID: 23826679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Race-Sex Differences in Statin Use and Low-Density Lipoprotein Cholesterol Control Among People With Diabetes Mellitus in the Reasons for Geographic and Racial Differences in Stroke Study.
    Gamboa CM; Colantonio LD; Brown TM; Carson AP; Safford MM
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28490523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.